AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Florentino, R. F.
Right arrow Articles by Sommer, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Florentino, R. F.
Right arrow Articles by Sommer, A.
Agricola
Right arrow Articles by Florentino, R. F.
Right arrow Articles by Sommer, A.

American Journal of Clinical Nutrition, Vol 52, 694-700, Copyright © 1990 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Tolerance of preschoolers to two dosage strengths of vitamin A preparation

RF Florentino, CC Tanchoco, AC Ramos, TS Mendoza, EP Natividad, JB Tangco and A Sommer
Department of Science and Technology, Food and Nutrition Research Institute, Manila, Philippines.

The tolerance to two alternative large-dosage strengths of vitamin A preparation was determined in a double-blind study involving 2471 children in two municipalities in the Philippines. Each child, aged 1-6 y, not suffering from active xerophthalmia or from nausea and/or vomiting, headache, diarrhea, and fever, was randomly given 1 mL of a syrupy suspension later identified to contain 0, 60, or 30 mg vitamin A. Clinical evaluation of subjects was done by physicians 24 h and 1 wk after dosing. Nausea and/or vomiting and headache were twice as common among children given 60 mg than those given 30 mg. Severe vomiting (1.2%) was confined to those given 60 mg. Almost all experienced their symptoms within 24 h after dosing; symptoms lasted for no more than 12- 24 h. The incidence of diarrhea and fever for vitamin A recipients was not significantly different from that of those receiving placebo.


This article has been cited by other articles:


Home page
 PediatricsHome page
H. S. Lam, C. M. Chow, W. T. Poon, C. K. Lai, K. C. A. Chan, W. L. Yeung, J. Hui, A. Y. W. Chan, and P. C. Ng
Risk of Vitamin A Toxicity From Candy-Like Chewable Vitamin Supplements for Children
Pediatrics, August 1, 2006; 118(2): 820 - 824.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
S Basu, B Sengupta, and P K R. Paladhi
Single megadose vitamin A supplementation of Indian mothers and morbidity in breastfed young infants
Postgrad. Med. J., July 1, 2003; 79(933): 397 - 402.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
D. A. Ross
Recommendations for Vitamin A Supplementation
J. Nutr., September 1, 2002; 132(9): 2902S - 2906.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
L. H. Allen and M. Haskell
Estimating the Potential for Vitamin A Toxicity in Women and Young Children
J. Nutr., September 1, 2002; 132(9): 2907S - 2919.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
K. P West Jr and A. Sommer
Vitamin A programme in Assam probably caused hysteria
BMJ, March 30, 2002; 324(7340): 791 - 791.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by The American Society for Nutrition